Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates.
Skvorak K, Liu J, Kruse N, Mehmood R, Das S, Jenne S, Chng C, Lao UL, Duan D, Asfaha J, Du F, Teadt L, Sero A, Ching C, Riggins J, Pope L, Yan P, Mashiana H, Ismaili MHA, McCluskie K, Huisman G, Silverman AP.
Skvorak K, et al. Among authors: jenne s.
J Inherit Metab Dis. 2023 Nov;46(6):1089-1103. doi: 10.1002/jimd.12662. Epub 2023 Aug 9.
J Inherit Metab Dis. 2023.
PMID: 37494004